Health Canada granted priority review to an application seeking approval of vamorolone, marketed in the U.S. as Agamree, for ...

The determination comes after recruitment and dosing in certain trials were paused after a young patient died due to acute ...

Columnist Patrick Moeschen, anticipating his own historic anniversary, celebrates champions of the disability rights movement ...